News & Media 

Sunovion Pharmaceuticals Canada Inc. is focused on the commercialization of prescription products in Canada. Our strategy is to license pharmaceuticals products that meet the needs of patients and the Canadian health care system. We are focused in the areas of cardiology, central nervous system and infectious disease.

Date	Title
8/23/2011	Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Acceptance of Lurasidone New Drug Submission for Treatment of Schizophrenia
8/17/2011	Sunovion Pharmaceuticals Canada Inc. Announces Company Name Change
6/3/2008	Sepracor Completes Acquisition of Oryx Pharmaceuticals and Expands Operations in Canada
5/1/2008	Sepracor to Acquire Oryx Pharmaceuticals Inc. and Expand Commercial Operations into Canada